Alcon Inc. (ALC) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Alcon Inc. (ALC:NYSE), powered by AI.

Current Price
$74.56
P/E Ratio
36.2
Market Cap
36.9B
Sector
Healthcare
What is the Alcon Inc. stock price forecast?

Alcon Inc. is currently trading at $74.56. View real-time AI analysis on Alpha Lenz.

What is Alcon Inc. insider trading activity?

View the latest insider trading data for Alcon Inc. on Alpha Lenz.

What is Alcon Inc.'s P/E ratio?

Alcon Inc.'s P/E ratio is 36.2.

Alcon Inc.

$74.56
NYSEALC
Ask about Alcon Inc.'s future dividend policy...
Alpha Chat Insight

Alcon Inc. trades at a P/E of 36.2 (premium valuation) with modest ROE of 4.8%.

Ask for details

Company Overview

Alcon Inc. is a leading global company in the field of ophthalmology, specializing in the development and manufacturing of eye care devices and pharmaceutical products. Its primary purpose is to enhance and protect visual health through a comprehensive portfolio that includes contact lenses, surgical products such as implantables, consumables, and advanced surgical equipment. Alcon serves diverse segments of the eye care market, providing solutions for conditions like cataracts, glaucoma, retinal diseases, and refractive errors. The company is known for ongoing innovation, conducting numerous clinical trials and maintaining an active pipeline of new products through collaborations with medical institutions and research leaders. With a history dating back to 1945 and operations in over 140 countries, Alcon plays a significant role in both the medical device and pharmaceutical sectors, improving quality of life for millions by partnering with eye care professionals and advancing global access to eye health solutions.

CEOMr. David J. Endicott
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees25,000

Company Statistics

(FY 2024)

Profile

Market Cap$36.86B
Revenue$9.91B
Shares Out0.00
Employees25,000

Margins

Gross55.62%
EBITDA27.29%
Operating14.26%
Pre-Tax12.67%
Net10.27%

Valuation

P/E36.21
P/B1.71
EV/Sales3.72
EV/EBITDA14.90
P/FCF26.20

Growth (CAGR)

Rev 3Yr6.13%
Rev 5Yr5.71%
Op Inc 3Yr34.56%
Op Inc 5YrN/A
Net Inc 3Yr39.38%
Net Inc 5YrN/A

Returns

ROA3.40%
ROE4.83%
ROIC4.83%

Financial Health

Cash & Cash Equivalents$1.68B
Net Debt$7.12B
Debt/Equity40.80%
Interest CovN/A
Ask Alpha Chat

Frequently Asked Questions

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Alcon Inc. (Healthcare) Stock Forecast & Analysis $74.56 | Alpha Lenz